Characteristics | Included n = 11 |
---|---|
Age (years) | 74 [68–78] |
Sex ratio (male; female) | 6;5 |
Living status | |
 Living alone | n = 5 (45%) |
 Living with partner | n = 6 (55%) |
Body mass index (kg/m2) | 29.1 [24.6–33.1] |
Smoking status | |
 Never | 1 (9%) |
 Former | 9 (82%) |
 Current | 1 (9%) |
Age-adjusted comorbidity index | |
 2–3 | 1 (9%) |
 4–5 | 3 (27%) |
 6+ | 7 (64%) |
ASA-classification | |
 I | 1 (9%) |
 II | 3 (27%) |
 III | 6 (55%) |
 IV | 1 (9%) |
VSAQ (METs) | 4 [3–5] |
VO2 at the VAT (mL/kg/min) | 9.3 [7.5–10.0] |
VO2peak (mL/kg/min)a | 14.8 [12.7–15.6] |
Hemoglobin level (mmol/L) | 7.1 [6.7–8.7] |
Albumin levels (g/L) | 37 [35–40] |
PG-SGA-SF score | |
 0 | 5 (45%) |
 2 | 2 (18%) |
 5+ | 4 (36%) |
Tumor location | |
 Colon | 8 (73%) |
 Rectum | 3 (27%) |
Tumor stage | |
 I | 5 (46%) |
 II | 3 (27%) |
 III | 3 (27%) |
Type of surgery | |
 Hemicolectomy | 8 (73%) |
 Other | 3 (27%) |
Surgical approach | |
 Open | 1 (9%) |
 Laparoscopic | 8 (73%) |
 Endoscopic | 1 (9%) |
 Conversion to open | 1 (9%) |
Received neoadjuvant treatment | 1 (9%) |